CLOV insider trading
Clover Health Investments, Corp. /De
In the past 36 days, 5 insiders sold $3.0M.
Insider purchases
No open-market purchases by insiders in this period.
Insider sales
| Insider | Value | Holdings | Plan | Traded / filed |
|---|---|---|---|---|
Jamie L. Reynoso CEO, Medicare Advantage |
$9K 2,006 sh @ $4.63 |
−0.1% | Pre-scheduled | Oct 7, 2026 Filed Oct 7, 2026 |
Jamie L. Reynoso CEO, Medicare Advantage |
$39K 8,750 sh @ $4.42 |
−0.3% | Pre-scheduled | Oct 5, 2026 Filed Oct 5, 2026 |
Andrew Toy Chief Executive Officer |
$1.3M 318,806 sh @ $4.19 |
−3.4% | Pre-scheduled | Oct 1, 2026 Filed Oct 2, 2026 |
Jamie L. Reynoso CEO, Medicare Advantage |
$9K 1,921 sh @ $4.56 |
−0.1% | Pre-scheduled | Sep 17, 2026 Filed Sep 18, 2026 |
Joseph Frank Oldakowski VP OF FINANCE AND CONTROLLER |
$15K 3,170 sh @ $4.64 |
−1.1% | Pre-scheduled | Sep 16, 2026 Filed Sep 17, 2026 |
Conrad Wai CEO, Counterpart Health |
$1.4M 300,000 sh @ $4.72 |
−20.4% | Pre-scheduled | Sep 15, 2026 Filed Sep 16, 2026 |
Jamie L. Reynoso CEO, Medicare Advantage |
$44K 9,273 sh @ $4.78 |
−0.3% | Pre-scheduled | Sep 15, 2026 Filed Sep 15, 2026 |
Karen Soares Chief Legal Officer |
$33K 6,846 sh @ $4.78 |
−0.4% | Pre-scheduled | Sep 15, 2026 Filed Sep 15, 2026 |
Joseph Frank Oldakowski VP OF FINANCE AND CONTROLLER |
$103K 20,000 sh @ $5.16 |
−6.7% | Not pre-scheduled | Sep 14, 2026 Filed Sep 14, 2026 |